nio752
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 9, 2022 (NCT05469360)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06372821 | Phase 1 | May 31, 2024 | Alzheimer's Association, University of London, University of Washington, Washington University in St. Louis |
| NCT05469360 | Phase 1 | Sep 9, 2022 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alzheimer's Association | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Novartis | For profit | 1 | 1 | 1 | 2022 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Washington University in St. Louis | Academic/Hospital | 1 | 0 | 1 | 2024 |
5 organizations
Page 1 / 1